Literature DB >> 19625342

Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse.

Chidozie J Amuzie1, Junko Shinozuka, James J Pestka.   

Abstract

Deoxynivalenol (DON), a trichothecene mycotoxin found in grains and cereal-based foods worldwide, impairs weight gain in experimental animals but the underlying mechanisms remain undetermined. Oral exposure to DON induces rapid and transient upregulation of proinflammatory cytokine expression in the mouse. The latter are known to induce several suppressors of cytokine signaling (SOCS), some of which impair growth hormone (GH) signaling. We hypothesized that oral exposure to DON will induce SOCS expression in the mouse. Real-time PCR and cytokine bead array revealed that oral gavage with DON rapidly (1 h) induced tumor necrosis factor-alpha and interleukin-6 mRNA and protein expression in several organs and plasma, respectively. Upregulation of mRNAs for four well-characterized SOCS (CIS [cytokine-inducible SH2 domain protein], SOCS1, SOCS2, and SOCS3) was either concurrent with (1 h) or subsequent to cytokine upregulation (2 h). Notably, DON-induced SOCS3 mRNAs in muscle, spleen and liver, with CIS1, SOCS1, and SOCS2 occurring to a lesser extent. Hepatic SOCS3 mRNA was a very sensitive indicator of DON exposure with SOCS3 protein being detectable in the liver well after the onset of cytokine decline (5 h). Furthermore, hepatic SOCS upregulation was associated with about 75% suppression of GH-inducible insulin-like growth factor acid labile subunit. Taken together, DON-induced cytokine upregulation corresponded to increased expression of several SOCS, and was associated with suppression of GH-inducible gene expression in the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625342      PMCID: PMC2766768          DOI: 10.1093/toxsci/kfp150

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  62 in total

Review 1.  The risk assessment paradigm and its application for trichothecenes.

Authors:  Angelika M Tritscher; Samuel W Page
Journal:  Toxicol Lett       Date:  2004-10-10       Impact factor: 4.372

Review 2.  Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

Authors:  Lynda A O'Sullivan; Clifford Liongue; Rowena S Lewis; Sarah E M Stephenson; Alister C Ward
Journal:  Mol Immunol       Date:  2007-01-17       Impact factor: 4.407

3.  Survey of deoxynivalenol in U.S. 1993 wheat and barley crops by enzyme-linked immunosorbent assay.

Authors:  M W Trucksess; F Thomas; K Young; M E Stack; W J Fulgueras; S W Page
Journal:  J AOAC Int       Date:  1995 May-Jun       Impact factor: 1.913

4.  The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine.

Authors:  D B Prelusky; H L Trenholm
Journal:  Nat Toxins       Date:  1993

Review 5.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

6.  Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone.

Authors:  J H Forsell; M F Witt; J H Tai; R Jensen; J J Pestka
Journal:  Food Chem Toxicol       Date:  1986-03       Impact factor: 6.023

7.  Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages.

Authors:  Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2008-05-22       Impact factor: 4.849

8.  Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line.

Authors:  S S Wong; H R Zhou; M L Marin-Martinez; K Brooks; J J Pestka
Journal:  Food Chem Toxicol       Date:  1998-05       Impact factor: 6.023

Review 9.  Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice.

Authors:  L Probert; K Akassoglou; L Alexopoulou; E Douni; S Haralambous; S Hill; G Kassiotis; D Kontoyiannis; M Pasparakis; D Plows; G Kollias
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

10.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  19 in total

1.  Critical role for peripherally-derived interleukin-10 in mediating the thermoregulatory manifestations of fever and hypothermia in severe forms of lipopolysaccharide-induced inflammation.

Authors:  Lois M Harden; Christoph Rummel; Helen P Laburn; Jelena Damm; Florian Wiegand; Stephen Poole; Rüdiger Gerstberger; Joachim Roth
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

2.  Characterization of deoxynivalenol-induced anorexia using mouse bioassay.

Authors:  Brenna M Flannery; Wenda Wu; James J Pestka
Journal:  Food Chem Toxicol       Date:  2011-05-07       Impact factor: 6.023

3.  Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression.

Authors:  Brenna M Flannery; Chidozie J Amuzie; James J Pestka
Journal:  Toxicology       Date:  2013-01-05       Impact factor: 4.221

4.  Effects of oral exposure to naturally-occurring and synthetic deoxynivalenol congeners on proinflammatory cytokine and chemokine mRNA expression in the mouse.

Authors:  Wenda Wu; Kaiyu He; Hui-Ren Zhou; Franz Berthiller; Gerhard Adam; Yoshiko Sugita-Konishi; Maiko Watanabe; Anthony Krantis; Tony Durst; Haibin Zhang; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-29       Impact factor: 4.219

5.  Body composition and hormonal effects following exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse.

Authors:  Kazuo Kobayashi-Hattori; Chidozie J Amuzie; Brenna M Flannery; James J Pestka
Journal:  Mol Nutr Food Res       Date:  2011-05-02       Impact factor: 5.914

Review 6.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

7.  Acute and subacute oral administration of mycotoxin deoxynivalenol exacerbates the pro-inflammatory and pro-pruritic responses in a mouse model of allergic dermatitis.

Authors:  Ryota Aihara; Toa Ookawara; Ai Morimoto; Naoki Iwashita; Yoshiichi Takagi; Atsushi Miyasaka; Masayo Kushiro; Shiro Miyake; Tomoki Fukuyama
Journal:  Arch Toxicol       Date:  2020-08-19       Impact factor: 5.153

8.  Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation.

Authors:  Chidozie J Amuzie; James J Pestka
Journal:  Toxicol Sci       Date:  2009-10-04       Impact factor: 4.849

9.  Combined Effect of Deoxynivalenol (DON) and Porcine Circovirus Type 2 (Pcv2) on Inflammatory Cytokine mRNA Expression.

Authors:  Chao Gu; Xiuge Gao; Dawei Guo; Jiacai Wang; Qinghua Wu; Eugenie Nepovimova; Wenda Wu; Kamil Kuca
Journal:  Toxins (Basel)       Date:  2021-06-13       Impact factor: 4.546

10.  Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response.

Authors:  Patricia M Cano; Julie Seeboth; François Meurens; Juliette Cognie; Roberta Abrami; Isabelle P Oswald; Laurence Guzylack-Piriou
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.